ZLAB
argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis – Zai Lab Limited
Thursday, January 20, 2022 1 min read
Key Takeaway: argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis – Zai Lab Limited
Full Press Release Details
argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis – Zai Lab Limited.